NIAID recently announced the appointment of five individuals to
senior management positions within the institute.
|Dr. Hugh Auchincloss, Jr.
Dr. Hugh Auchincloss, Jr., has been named new principal deputy
director of NIAID. He will serve as second in command to NIAID
director Dr. Anthony Fauci and will have broad responsibilities
for carrying out the institute's programs. Auchincloss joins NIAID
from Massachusetts General Hospital, where, as professor of surgery
at Harvard Medical School, he earned an international reputation
in the field of organ transplantation. An immunologist, Auchincloss
is the founder and director of the Juvenile Diabetes Research Foundation
Center for Islet Transplantation at Harvard Medical School. He
has spent much of his time in recent years as chief operating officer
of NIAID's Immune Tolerance Network. He also serves as chairman
of the FDA's subcommittee on xenotransplantation. He was elected
president of the American Society of Transplantation in 2005.
||Dr. H. Clifford Lane
Dr. H. Clifford Lane has been appointed deputy director for clinical
research and special projects. Previously he served as NIAID's
acting principal deputy. Lane will continue to serve as director
of the newly established Division of Clinical Research. In his
new position, he will also function as a liaison with the Departments
of Defense and Homeland Security and other outside constituents.
|Dr. John J. McGowan
Dr. John J. McGowan has been appointed to the new position of
deputy director for science management. He will have overall responsibility
for directing NIAID's business and administrative requirements
as well as its science planning, policy and integration. A virologist
by training, McGowan has served in multiple roles at NIAID including
chief of the Developmental Therapeutics Branch and associate director
for the Basic Research and Development Program, both within the
institute's Division of AIDS. Most recently, he served as director
of the Division of Extramural Activities, a position he held since
1991, and as acting NIAID associate director for management and
operations since December 2004.
||Dr. Kathryn Zoon
Dr. Kathryn Zoon has been appointed director of the Division of
Intramural Research, replacing Dr. Thomas Kindt. Since June 2005,
following Kindt's retirement, she has served as acting director
of DIR and, since June 2004, she was deputy director for planning
and development at DIR. Previously, she was the principal deputy
director of the Center for Cancer Research at the National Cancer
Institute, and prior to that she was director of the Center for
Biologics Evaluation and Research at FDA.
Zoon is an associate editor of the Journal of Interferon Research and
serves on the board of directors of the Foundation for Advanced
Education in the Sciences. The recipient of numerous awards, she
was elected to the Institute of Medicine in 2002.
Gregory Folkers has been appointed chief of staff to Fauci, leading
the newly created Immediate Office of the Director. Folkers came
to NIAID in 1991 after being employed in various writing and communications
positions in the Boston area. After working as a science writer
and editor in the NIAID Office of Communications, he has for the
past decade worked directly with Fauci as a special assistant and
senior public affairs advisor.
NIDCR Mourns Former Director Kreshover
Dr. Seymour J. Kreshover, 93, former director of NIDR (now NIDCR)
died Jan. 23 at his home in Winter Park, Fla. A dentist, physician
and researcher, he is remembered for broadening dental research
and linking it to the biomedical sciences and medicine. He headed
NIDR from 1966 to 1975.
"Dr. Kreshover was an outstanding leader, a dedicated public servant
and an extraordinary scientist who made numerous contributions
to dental and oral health research," said NIDCR director Dr. Lawrence
Tabak. "He was also a friendly and thoughtful man who was liked
and respected at the institute and by the wider research community.
It was a joy to see him each year at the NIDCR lecture named in
|Dr. Seymour J. Kreshover
Kreshover's efforts to connect dentistry to the biomedical sciences
led him to expand the institute's research areas and to encourage
basic research throughout the programs. He created laboratories
on neurobiology and developmental biology whose research laid the
foundation for future discoveries on pain and on normal and abnormal
craniofacial development. His goal of broadening dental science
also gave rise to a new program of dental research centers in universities.
The centers attracted scientists from disciplines not traditionally
associated with dentistry and provided a venue for training researchers.
During his tenure, Kreshover also established a national program
aimed at reducing the incidence of dental caries. Basic and applied
research from the National Caries Program resulted in an enhanced
understanding of the dental caries process, better dental sealants
and the promotion of fluoride applications through school-based
mouth rinse programs.
A native of New York City, Kreshover earned a B.A. from New York
University in 1934. In 1938, he received a D.D.S. from the University
of Pennsylvania School of Dentistry and then in 1942 received a
Ph.D. in clinical medicine and pathology from Yale University.
He also went on to earn an M.D. from NYU School of Medicine in
After receiving his M.D., Kreshover joined the Medical College
of Virginia where he served as a professor and clinician in the
department of oral pathology, director of dental research and director
of postgraduate and graduate studies.
He arrived at NIDR in 1956 and initially headed the institute's
Intramural Research Program. In 1966, he was named director. A
member of the Public Health Service Commissioned Corps, he assumed
the rank of assistant surgeon general when he rose to the director
Kreshover was the recipient of numerous honors and awards, including
the Department of Health, Education and Welfare Distinguished Service
Medal; the PHS Meritorious Service Award, the Pierre Fauchard Medal,
the Henry Spenadel Award and the Alfred C. Fones Memorial Award.
He had several honorary degrees and also held membership in a number
of medical and dental associations. In 1983, NIDR established the
annual Kreshover Lecture Series in his honor.
When not working, Kreshover enjoyed spending time with his family.
He could also be found sailing as well as collecting and showing
classic cars, including such vintage models as a 1953 MG-TD, Jaguar
XKE and Jaguar 120. In addition, he was a skilled woodworker who
had taken woodworking classes and also maintained a workshop devoted
to the hobby.
He is survived by his wife of 59 years, Jacqueline Kreshover of
Winter Park; four children, Karen Davis of Gaithersburg, Douglas
Kreshover of Vienna, Janis Kasch of Ormond Beach, Fla., and Lauren
Watkins of Windermere, Fla.; 13 grandchildren; and three great-grandchildren.
NINDS's Nelson Retires With 35 Years of Federal
Dr. Karin Nelson, acting chief of the NINDS Neuroepidemiology
Branch, retired Jan. 3 with 35 years of federal service, all with
NINDS. "It's truly been a privilege to work at NIH," she said.
Nelson earned her undergraduate degree from the University of Minnesota
and her medical degree from the University of Chicago School of
Medicine in 1957. She then trained in neurology at the University
of Maryland, George Washington University and the National Hospital,
Queen Square, London.
||Dr. Karin Nelson
She first came to NIH in 1964 as a medical officer in the Perinatal
Research Branch, working on NINDS's National Collaborative Perinatal
Project (NCPP). The project was a large multicenter prospective
study of factors related to developmental disability with such
disorders as cerebral palsy, epilepsy and mental retardation. The
study followed 50,000 women throughout their pregnancies and their
children through age 8.
"I came to NIH because there was great controversy about what
to do about febrile seizures. It was the question I was asked about
most often by parents and colleagues, at lunch and in the parking
lot," said Nelson. Febrile seizures are convulsions brought on
by a fever in infants or small children. "As febrile seizures are
among the most common disorders in child neurology, it seemed that
there ought to be answers. And the NCPP at NINDS had data that
would make it possible to get some evidence-based answers. The
results of that research contributed to changes in medical practice
with regard to this common disorder," she said.
In 1967 Nelson left NIH to become a neurology instructor at George
Washington University and an associate neurologist at Children's
Hospital in Washington, D.C. She returned to NIH in 1973 as a medical
officer in the Neuroepidemiology Branch, NINDS. Later she became
acting chief of the branch, the position she held at retirement.
In addition to her NINDS responsibilities, Nelson continued to
serve as professor of neurology at GW.
During her tenure at NINDS, she studied the natural history and
etiology of major childhood neurological problems — focusing on cerebral
palsy, epilepsy, neonatal seizures, febrile seizures and the neurological
outcome in multiple births. Her work often led to collaborations
with researchers across the country and worldwide including the
California state department of health and the University of Adelaide
Nelson has authored or coauthored numerous articles, reviews and
book chapters that together constitute a major part of current
scientific knowledge about child neurology.
Not surprisingly, her research has garnered her many awards including
the Bernard Sachs and Hower Awards from the Child Neurology Society,
the Distinguished Basic Neuroscientist Epilepsy Research Award
from the American Epilepsy Society and the Milken Family Medical
Foundation, and NIH Director's and Merit Awards.
In retirement, Nelson plans to work part-time at Children's National
Four Join NIAID Advisory Council
Four new members recently joined the National Advisory Allergy
and Infectious Diseases Council for 4-year terms. They are: Dr.
Barbara A. Baird of Cornell University; Dr. Kathryn M. Edwards
of Vanderbilt University; Dr. Martin Rosenberg of Promega Corp.
in Madison, Wisc.; and Dr. Megan Sykes of Harvard Medical School.
|NIAID director Dr. Anthony
Fauci (r) welcomes four new members to his council. They are
(from l) Dr. Megan Sykes, Dr. Martin Rosenberg, Dr. Barbara
Baird and Dr. Kathryn Edwards.
Baird is a professor in the department of chemistry and chemical
biology at Cornell. She also serves as director of the Nanobiotechnology
Center and is principal investigator for Cornell's training grant
in molecular biophysics.
Edwards is professor of pediatrics at Vanderbilt. She was principal
investigator of the NIAID-funded, placebo-controlled influenza
efficacy trial comparing live, attenuated and inactivated influenza
vaccines in more than 3,000 volunteers and now leads the NIAID-supported
vaccine and treatment evaluation unit at Vanderbilt.
Rosenberg is chief scientific officer of Promega and is an adjunct
professor in the department of bacteriology at the University of
Wisconsin and in the department of biochemistry at the Robert Wood
Johnson Medical School.
Sykes is the Harold and Ellen Danser professor in the department
of surgery and a professor of medicine at Harvard Medical School.
She is an immunologist and associate director of the Transplantation
Biology Research Center at Massachusetts General Hospital.
to top of page